HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ralph Wäsch Selected Research

Immune System Diseases (Immune Disorders)

1/2021Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ralph Wäsch Research Topics

Disease

37Multiple Myeloma
06/2023 - 07/2006
16Neoplasms (Cancer)
05/2024 - 01/2005
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 06/2012
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2023 - 09/2012
6Graft vs Host Disease (Graft-Versus-Host Disease)
10/2022 - 12/2009
5Anemia
10/2023 - 01/2018
5Leukemia
05/2023 - 12/2009
5Hematologic Neoplasms (Hematological Malignancy)
11/2021 - 09/2012
4Bronchiolitis Obliterans Syndrome
10/2022 - 07/2010
4Immunoglobulin Light-chain Amyloidosis
01/2018 - 04/2013
4Primary Myelofibrosis (Myelosclerosis)
01/2018 - 01/2014
3Thrombocytopenia (Thrombopenia)
10/2023 - 01/2018
3Genomic Instability
01/2022 - 01/2005
3Lung Neoplasms (Lung Cancer)
01/2021 - 01/2014
3Lymphoma (Lymphomas)
01/2018 - 12/2009
2Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2024 - 10/2012
2Infections
11/2023 - 01/2021
2Philadelphia Chromosome
10/2023 - 01/2018
2Paraproteinemias (Monoclonal Gammopathy)
01/2021 - 11/2017
2Fatigue
01/2021 - 11/2009
2Smoldering Multiple Myeloma
01/2021 - 03/2016
2Residual Neoplasm
10/2020 - 06/2005
2Disease Progression
01/2018 - 03/2016
2Splenomegaly
01/2018 - 01/2014
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2018 - 01/2014
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 01/2014
1cell-associated neurotoxicity
05/2024
1Stomatitis
11/2023
1Neutropenia
10/2023
1Leukopenia
10/2023
1Heart Diseases (Heart Disease)
10/2023
1Toxic Optic Neuropathy
06/2023
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2023
1COVID-19
10/2022
1Hypercalcemia (Milk Alkali Syndrome)
08/2021
1Human Influenza (Influenza)
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Hemolysis
01/2021
1Immune System Diseases (Immune Disorders)
01/2021

Drug/Important Bio-Agent (IBA)

7carfilzomibIBA
01/2023 - 01/2018
7Lenalidomide (CC 5013)FDA Link
01/2023 - 02/2012
7Bortezomib (Velcade)FDA Link
01/2021 - 09/2010
5DecitabineFDA Link
11/2023 - 01/2018
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2023 - 03/2016
4Chimeric Antigen ReceptorsIBA
05/2024 - 01/2021
4Sorafenib (BAY 43-9006)FDA Link
10/2020 - 04/2013
4Proteins (Proteins, Gene)FDA Link
11/2017 - 12/2013
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2023 - 07/2016
3Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2022 - 06/2012
3Anaphase-Promoting Complex-CyclosomeIBA
01/2021 - 01/2005
3Cyclin BIBA
01/2021 - 01/2013
3ruxolitinibIBA
01/2021 - 01/2014
3Proteasome InhibitorsIBA
01/2021 - 01/2018
3Antimitotic AgentsIBA
01/2021 - 01/2013
2daratumumabIBA
01/2023 - 01/2021
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022 - 01/2021
2UbiquitinIBA
01/2022 - 01/2021
2ParaproteinsIBA
08/2021 - 11/2017
2Bendamustine HydrochlorideFDA Link
01/2021 - 10/2012
2Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 11/2003
2venetoclaxIBA
01/2021 - 01/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 10/2018
2Interleukin-15 (Interleukin 15)IBA
04/2018 - 01/2018
2pomalidomideIBA
01/2018 - 01/2014
2Tyrosine Kinase InhibitorsIBA
01/2018 - 01/2018
2Immunomodulating AgentsIBA
01/2018 - 01/2018
2Transcription Factors (Transcription Factor)IBA
11/2017 - 10/2017
2Diphosphonates (Bisphosphonates)IBA
03/2016 - 06/2012
2Immunoglobulin G (IgG)IBA
10/2015 - 11/2009
2posaconazoleFDA Link
10/2013 - 09/2012
1EnzymesIBA
10/2023
1Inotuzumab OzogamicinIBA
10/2023
1Hemoglobins (Hemoglobin)IBA
10/2023
1belantamab mafodotinIBA
06/2023
1palbociclibIBA
05/2023
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2023
1Inosine Triphosphate (ITP)IBA
01/2023
1Messenger RNA (mRNA)IBA
10/2022
1VaccinesIBA
10/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022
1CyclinsIBA
01/2022
1AntibodiesIBA
10/2021
1Immunoconjugates (Immunoconjugate)IBA
10/2021
1EverolimusFDA Link
08/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
08/2021
1Calcineurin InhibitorsIBA
08/2021
1eculizumabFDA Link
01/2021
1AlgiporeIBA
01/2021
1GlucocorticoidsIBA
01/2021

Therapy/Procedure

22Therapeutics
10/2023 - 08/2010
11Cell Transplantation
10/2022 - 06/2005
6Hematopoietic Stem Cell Transplantation
12/2023 - 01/2018
5Stem Cell Transplantation
07/2023 - 01/2018
4Drug Therapy (Chemotherapy)
07/2023 - 01/2011
3Immunotherapy
05/2024 - 01/2018
3Transplantation
10/2022 - 06/2012
3Homologous Transplantation
01/2019 - 02/2012
2Blood Component Removal (Apheresis)
01/2021 - 01/2017
1Drug Tapering
06/2023
1Renal Dialysis (Hemodialysis)
01/2023